CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib in Treating Patients With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1